Taysha Gene Therapies (TSHA) EBT Margin (2023 - 2025)
Taysha Gene Therapies (TSHA) reported EBT Margin of 2099.17% for Q4 2025, down 138928.0% on a YoY basis from N/an in Q4 2024, and up 18.52% sequentially from 2576.33% in Q2 2025.
Taysha Gene Therapies (TSHA) EBT Margin (2023 - 2025) Analysis & Trends
Taysha Gene Therapies (TSHA) has 3 years of EBT Margin data on file, last reported at 2099.17% in Q4 2025.
- For the quarter ending Q4 2025, EBT Margin fell 138928.0% year-over-year to 2099.17%; the trailing twelve-month figure through Mar 2026 stood at 7401.81% (down 566762.0% YoY), and the FY2025 full-year result was 3326.38%, down 94247.0% from the prior year.
- EBT Margin rose to 2099.17% in Q4 2025, from 2576.33% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 433.19% in Q4 2023 to a low of 2957.21% in Q3 2024.
- A 3-year average of 1565.04% and a median of 1242.14% in 2025 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin slumped 240863 bps in 2024 and surged 7250 bps in 2025, its largest moves.
- Tracing TSHA's EBT Margin over 3 years: stood at 433.19% in 2023, then sank by 64 bps to 709.89% in 2024, then tumbled by 196 bps to 2099.17% in 2025.
- Business Quant data shows TSHA's EBT Margin at 2099.17% in Q4 2025, 2576.33% in Q2 2025, and 1242.14% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Taysha Gene Therapies | 2.14 Bn | 2.14 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2,099.17% |
| Jun 30, 2025 | -2,576.33% |
| Mar 31, 2025 | -1,242.14% |
| Dec 31, 2024 | -709.89% |
| Sep 30, 2024 | -2,957.21% |
| Jun 30, 2024 | -2,648.83% |
| Mar 31, 2024 | -1,082.56% |
| Dec 31, 2023 | -433.19% |
| Sep 30, 2023 | -548.59% |
| Jun 30, 2023 | -2,318.62% |
| Mar 31, 2023 | -598.90% |